glp 1 agonist mechanism of action Frontiers Current Insights, Advantages and Challenges
Description
Type 2 diabetes
Nutritional considerations for off-label use Some individuals use microdosing, spaced out dosing, or lower compounded dosing of GLP-1s
GLP-1s, such as semaglutide (sold as Ozempic and Wegovy) and tirzepatide (sold as Mounjaro and Zepbound), are commonly used to treat Type 2 diabetes and obesity and can reduce cardiovascular and kidney disease risks, but researchers still are exploring potential risks of these medications
GLP-1based therapies are powerful
Fundamental processes affected by GLP-1s In some cases, the problems GLP-1s can solve stem directly from their weight reduction effect
